Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2011 | 05-2011 | 02-2011 | 11-2010 | 08-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | -167 | 204 | 197 | 266 | 203 |
| Accounts receivable | -908 | -427 | -1,416 | -781 | 1,786 |
| Other Working Capital | -5,401 | -2,286 | -3,383 | -818 | -2,994 |
| Other Operating Activity | -2,861 | -5,647 | -3,336 | 21,719 | -4,430 |
| Operating Cash Flow | $-9,338 | $-8,155 | $-7,939 | $20,386 | $-5,435 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131 | -13 | -42 | -50 | -39 |
| Purchase Of Investment | -325 | -1,267 | -27,501 | 0 | 0 |
| Sale Of Investment | 9,322 | 9,223 | 8,772 | 3,501 | 4,367 |
| Investing Cash Flow | $8,866 | $7,942 | $-18,771 | $3,451 | $4,328 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | N/A | -120 | 121 |
| Other Financing Activity | 12 | 671 | 5 | 129 | -86 |
| Financing Cash Flow | $12 | $671 | $5 | $9 | $34 |
| Beginning Cash Position | 1,034 | 544 | 27,248 | 2,235 | 3,314 |
| End Cash Position | 516 | 1,034 | 544 | 26,139 | 2,235 |
| Net Cash Flow | $-460 | $458 | $-26,704 | $23,846 | $-1,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,338 | -8,155 | -7,939 | 20,386 | -5,435 |
| Capital Expenditure | -131 | -13 | -42 | -50 | -39 |
| Free Cash Flow | -9,468 | -8,168 | -7,981 | 20,336 | -5,474 |